Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.
about
Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA)Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-AnalysisHighly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005.Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trialHead-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabsMycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.Comparison of flocked and aptima swabs and two specimen transport media in the aptima combo 2 assay.Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study.Sexually transmitted diseases treatment guidelines, 2015.Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women.Chlamydia trachomatis Infection: Screening and Management.Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeaeComparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium.Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.Gonorrhea infection in women: prevalence, effects, screening, and management.Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.High prevalence of rectal gonorrhea and Chlamydia infection in women attending a sexually transmitted disease clinic.Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?Can e-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs?Chlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinics.Adolescent women can perform a point-of-care test for trichomoniasis as accurately as cliniciansComparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.Using sexually transmitted infection biomarkers to validate reporting of sexual behavior within a randomized, experimental evaluation of interviewing methods.Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samplesRisk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up?Can mailed swab samples be dry-shipped for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by nucleic acid amplification tests?Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test studyAssessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy studyDepot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women.APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae.Comparison of the cobas 4800 CT/NG test with culture for detecting Neisseria gonorrhoeae in genital and nongenital specimens in a low-prevalence population in New Zealand.Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical settingTesting for sexually transmitted infections: a brave new world?Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin.Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial.Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial.Should we consider alternatives to combined cervical and urethral swabs for detection of Chlamydia trachomatis in females?
P2860
Q21254704-8ECC403A-ECB3-4074-AD0C-966997D91B9EQ27025596-27ECC8A9-DAF5-4381-9550-185FA8BA39BDQ33559141-77C5072C-008B-4729-A6C6-30ED04B140D7Q33720510-DEF1BBED-2547-4930-BDC9-D4DAE3D69313Q33778605-25786C57-F561-4B37-94FD-FAAAE9C6A2DAQ33900186-9F7E86C0-5D4A-40CF-B446-56E5E8DCB141Q34076727-D73BEBC0-D535-4A19-9483-AA533C5D5191Q34298139-56830F45-A010-4A44-B6F2-74D441E4BF2BQ34431657-FD354C19-D5D5-4B4A-AF51-96A7F0D3EBF9Q34479272-1EBF4784-40E3-4B60-85A1-10EA22F46B1BQ34479432-A43E8209-534A-41F8-A5DA-346AC8F5B50CQ34785987-E885C005-6916-4362-A751-A0162ACFC4CCQ34990143-3F447910-E96B-4B9B-AFF0-26C12E5F6C0BQ35073368-F6885035-84D2-4EF3-881A-43B06F1B3CC6Q35141880-5DB38E7C-54EE-4210-8896-61CB4E919DA8Q35147305-F95D1E28-838A-4015-B131-0E4FF6D02522Q35167336-858B152D-3E3F-4645-91D2-CDF7BCB68397Q35189064-A605551F-475A-4183-8CD1-BA6315737BEBQ35221073-4D7B16E7-1FD1-4649-A981-37F706539E8EQ35276004-45693AC6-2FF2-404B-B782-A1F40F2DE604Q35277395-6FD29095-1498-4454-9134-EF4E18A57AC4Q35564943-DEC7E40D-190F-4739-AB48-26B86916D481Q35763113-AAAC2DA1-0D2A-41B8-A062-8FD04B65B4F1Q35784603-898111F0-0038-44E9-B923-0C43CC13750DQ35792083-1556FBFA-1855-4149-8CE9-174D7EC09C43Q35947414-980EC988-A10B-44A2-8CC7-26E9E57C7042Q36075286-36421AEE-F6C5-468A-A667-1A038F7310C0Q36175296-27F44E63-FF19-4BD9-A9D5-8F68C2123083Q36183847-D73F10F2-78C2-4630-95EE-2E671CD80C1EQ36462147-8499498F-4E00-41FD-8F3C-8D81DE615C9AQ36462151-B2F77382-8A24-4E44-8A4F-CA7BDF3E4293Q36488387-2CD564EA-25C9-47E9-AEC4-70057315E9F3Q36528856-7B7B7187-B04D-4CF1-86C1-6981CCE2FAA1Q36826778-B549097B-B4BA-4A47-A21A-71E13C998AA6Q36900768-66F0C9F0-1994-4D70-BE28-6F43D5604CACQ36928699-339DE4EA-F346-4809-9193-99951903B203Q36928828-D47EB42E-6A71-4A48-A3E4-A44B2AFB3632Q37006224-B8FDCE85-C7DE-4566-AE38-FE4F8ED28E49Q37006265-07D4B9E1-1A78-4FD2-8868-2F4380B8451AQ37006334-6FB96E3B-74CE-497C-8030-3682A5C4954A
P2860
Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaginal swabs are the specimen ...... MA assays for both infections.
@en
Vaginal swabs are the specimen ...... MA assays for both infections.
@nl
type
label
Vaginal swabs are the specimen ...... MA assays for both infections.
@en
Vaginal swabs are the specimen ...... MA assays for both infections.
@nl
prefLabel
Vaginal swabs are the specimen ...... MA assays for both infections.
@en
Vaginal swabs are the specimen ...... MA assays for both infections.
@nl
P2093
P921
P1476
Vaginal swabs are the specimen ...... MA assays for both infections.
@en
P2093
David H Martin
Dean E Willis
Deanna Fuller
Edward W Hook
Jeanne A Jordan
Julius Schachter
Max A Chernesky
Paul M Fine
William Janda
P304
P356
10.1097/01.OLQ.0000190092.59482.96
P577
2005-12-01T00:00:00Z